Voyageur Tax Free Funds has released its latest financial report, revealing a stable financial position as of August 31, 2026. The firm reported total assets of approximately $533.4 million and net assets of around $527.6 million. This update is significant for investors seeking tax-free income options, as it showcases the firm’s ongoing stability in a competitive market.
The filing indicates that Voyageur Tax Free Funds is committed to maintaining its position in the investment industry. The report highlights a total liability of about $5.8 million, which is relatively low compared to its total assets. This financial health is crucial for investors, particularly in the municipal bond sector, where the firm primarily operates.
Background
Voyageur Tax Free Funds is an investment firm that specializes in tax-free municipal bond funds. The company operates under the Central Index Key (CIK) number 0000733362. The firm has undergone several name changes in its history, previously known as Voyageur Minnesota Tax Free Funds Inc and Double Exempt Flex Fund Inc. The firm is registered under the SEC Act of 1940, with a filing number of 811-03910.
What the Filing Says
The recent filing, submitted on October 29, 2026, includes detailed financial metrics. According to the report, "total assets" were recorded at $533,388,883.72, while "net assets" stood at $527,551,030.34. The firm also reported a total liability of $5,837,853.38, indicating a solid asset-to-liability ratio.
Impact
This financial update may influence various stakeholders, including investors and analysts focusing on tax-free investment opportunities. The stability shown in the report could attract new investors looking for reliable options in the municipal bond market. Additionally, existing investors may feel reassured about their investments in the firm.
What's Next
The filing does not say what happens next. However, stakeholders can expect continued monitoring of the firm’s performance in upcoming quarters, as the investment landscape evolves.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






